Honors

Dr. Geschwind is recognized internationally as an expert and key opinion leader in liver cancer. He was the lead or co-investigator on more than 50 clinical trials testing innovative treatments for patients with liver cancer funded by pharmaceutical companies, foundations and/or the NIH. Some of these trials were care changing. He also received multiple patents for research on a new promising drug that targets a specific pathway in cancer cells, which allowed him to create a company based on this discovery.